These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9654906)
21. Low-intensity voluntary running lowers blood pressure with simultaneous improvement in endothelium-dependent vasodilatation and insulin sensitivity in aged spontaneously hypertensive rats. Sun MW; Qian FL; Wang J; Tao T; Guo J; Wang L; Lu AY; Chen H Hypertens Res; 2008 Mar; 31(3):543-52. PubMed ID: 18497475 [TBL] [Abstract][Full Text] [Related]
22. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy. Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats. Ruffolo RR; Kurz K; Paget CJ J Pharmacol Exp Ther; 1985 Jan; 232(1):134-8. PubMed ID: 3838104 [TBL] [Abstract][Full Text] [Related]
24. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension. Jacobs MC; Lenders JW; Willemsen JJ; Thien T J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663 [TBL] [Abstract][Full Text] [Related]
25. [Tonocardin in complex treatment of diabetes mellitus concurrent with hypertension]. Balabolkin MI; Khasanova ER; Trukhina TV; Kreminskaia VM Ter Arkh; 2002; 74(12):38-41. PubMed ID: 12577838 [TBL] [Abstract][Full Text] [Related]
26. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load. Friberg P Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269 [TBL] [Abstract][Full Text] [Related]
27. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats. Greeberg S J Pharmacol Exp Ther; 1980 Nov; 215(2):279-86. PubMed ID: 7441494 [TBL] [Abstract][Full Text] [Related]
28. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. Christensen KL; Jespersen LT; Mulvany MJ J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB). Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764 [TBL] [Abstract][Full Text] [Related]
30. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats. Harland D; Brown MJ J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445 [TBL] [Abstract][Full Text] [Related]
31. Influence of alpha 1- and alpha 2-adrenoceptor antagonist therapy on the development of hypertension in spontaneously hypertensive rats. Young RL; Jonsson JR; Mano MT; Frewin DB; Head RJ J Cardiovasc Pharmacol; 1993 May; 21(5):786-90. PubMed ID: 7685450 [TBL] [Abstract][Full Text] [Related]
32. Hemodynamic and vascular activity of LY127210, a new vasodilator, in anesthetized spontaneously hypertensive rats: comparison with hydralazine. Steinberg MI; Keller CE; Bemis KG Clin Exp Hypertens A; 1985; 7(10):1481-97. PubMed ID: 3841035 [TBL] [Abstract][Full Text] [Related]
33. Functional tolerance to alpha-adrenergic receptor blockade in the spontaneously hypertensive rat highlights the multifunctional role of vascular angiotensin II in the development of hypertension. Smid SD; Frewin DB; Wyartt CL; Head RJ J Vasc Res; 1995; 32(4):247-53. PubMed ID: 7654881 [TBL] [Abstract][Full Text] [Related]
35. Effects of preweaning doxazosin treatment on adult pressure in the spontaneously hypertensive rat. Boesen EI; Lewis TV; Kett MM; Anderson WP Clin Exp Pharmacol Physiol; 2003 Aug; 30(8):555-7. PubMed ID: 12890177 [TBL] [Abstract][Full Text] [Related]
36. Pharmacology of budralazine, a new antihypertensive drug. Akashi A; Chiba T; Suzuki I; Hashimoto H Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):134-46. PubMed ID: 736687 [TBL] [Abstract][Full Text] [Related]
37. Direct Vasodilators and Sympatholytic Agents. McComb MN; Chao JY; Ng TM J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):3-19. PubMed ID: 26033778 [TBL] [Abstract][Full Text] [Related]
38. Neural mechanisms in primary hypertension. Efficacy of alpha-blockade with doxazosin during stress. Lee D; Lu ZW; DeQuattro V Am J Hypertens; 1996 Jan; 9(1):47-53. PubMed ID: 8834706 [TBL] [Abstract][Full Text] [Related]
39. Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension. Wilner KD; Ziegler MG Am J Cardiol; 1987 May; 59(14):82G-86G. PubMed ID: 2884858 [TBL] [Abstract][Full Text] [Related]
40. Alpha-adrenoceptor blockade in patients with mild to moderate hypertension: long-term renal effects of doxazosin. Krusell LR; Christensen CK; Pedersen OL J Cardiovasc Pharmacol; 1992 Sep; 20(3):440-4. PubMed ID: 1279290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]